110 related articles for article (PubMed ID: 24247994)
1. Reversible vigabatrin-induced life-threatening encephalopathy.
Hernández Vega Y; Kaliakatsos M; U-King-Im JM; Lascelles K; Lim M
JAMA Neurol; 2014 Jan; 71(1):108-9. PubMed ID: 24247994
[No Abstract] [Full Text] [Related]
2. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
Lotan E; Bluvstein J; Zan E
Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
[No Abstract] [Full Text] [Related]
3. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
Dill P; Datta AN; Weber P; Schneider J
Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
[TBL] [Abstract][Full Text] [Related]
4. Cerebral MRI abnormalities associated with vigabatrin therapy.
Pearl PL; Vezina LG; Saneto RP; McCarter R; Molloy-Wells E; Heffron A; Trzcinski S; McClintock WM; Conry JA; Elling NJ; Goodkin HP; de Menezes MS; Ferri R; Gilles E; Kadom N; Gaillard WD
Epilepsia; 2009 Feb; 50(2):184-94. PubMed ID: 18783433
[TBL] [Abstract][Full Text] [Related]
5. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
[No Abstract] [Full Text] [Related]
6. Vigabatrin administration in patients with infantile spasms: the risks.
Jaseja H
Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
[No Abstract] [Full Text] [Related]
7. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
Schonstedt V; Stecher X; Venegas V; Silva C
Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
[TBL] [Abstract][Full Text] [Related]
8. Reversible magnetic resonance imaging and spectroscopy abnormalities in the course of vigabatrin treatment for West syndrome.
Thelle T; Gammelgaard L; Hansen JK; Østergaard JR
Eur J Paediatr Neurol; 2011 May; 15(3):260-4. PubMed ID: 20926323
[TBL] [Abstract][Full Text] [Related]
9. Pathological evidence of vacuolar myelinopathy in a child following vigabatrin administration.
Horton M; Rafay M; Del Bigio MR
J Child Neurol; 2009 Dec; 24(12):1543-6. PubMed ID: 19773459
[TBL] [Abstract][Full Text] [Related]
10. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
[TBL] [Abstract][Full Text] [Related]
11. Vigabatrin therapy in infantile spasms: solving one problem and inducing another?
Wohlrab G; Leiba H; Kästle R; Ramelli G; Schmitt-Mechelke T; Schmitt B; Landau K
Epilepsia; 2009 Aug; 50(8):2006-8. PubMed ID: 19682036
[No Abstract] [Full Text] [Related]
12. Acute encephalopathy associated with vigabatrin in a six-month-old girl.
Haas-Lude K; Wolff M; Riethmüller J; Niemann G; Krägeloh-Mann I
Epilepsia; 2000 May; 41(5):628-30. PubMed ID: 10802771
[TBL] [Abstract][Full Text] [Related]
13. An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.
Fong CY; Osborne JP; Edwards SW; Hemingway C; Hancock E; Johnson AL; Kennedy CR; Kneen R; Likeman M; Lux AL; Mordekar SR; Murugan V; Newton RW; Pike M; Quinn M; Spinty S; Vassallo G; Verity CM; Whitney A; O'Callaghan FJ
Dev Med Child Neurol; 2013 Sep; 55(9):862-7. PubMed ID: 23789722
[TBL] [Abstract][Full Text] [Related]
14. Vigabatrin monotherapy for infantile spasms.
Gaily E
Expert Rev Neurother; 2012 Mar; 12(3):275-86. PubMed ID: 22364326
[TBL] [Abstract][Full Text] [Related]
15. Therapy of infantile spasms: new opportunities and emerging challenges.
Mikati MA; Cornett KM
Epilepsy Behav; 2010 Apr; 17(4):571-3. PubMed ID: 20097137
[No Abstract] [Full Text] [Related]
16. Is the risk of vigabatrin-attributed visual field loss lower in infancy than in later life?
Riikonen R
Epilepsia; 2009 Aug; 50(8):2005-6. PubMed ID: 19682035
[No Abstract] [Full Text] [Related]
17. Non-vision adverse events with vigabatrin therapy.
Walker SD; Kälviäinen R
Acta Neurol Scand Suppl; 2011; (192):72-82. PubMed ID: 22061182
[TBL] [Abstract][Full Text] [Related]
18. Globus pallidus restricted diffusion associated with vigabatrin therapy.
Trindade RAR; Wainstein B; Campos LG; Pérez JA; Bianchin MM; Vedolin LM; Duarte JÁ
Arq Neuropsiquiatr; 2018 Feb; 76(2):127-128. PubMed ID: 29489970
[No Abstract] [Full Text] [Related]
19. The potential for vigabatrin-induced intramyelinic edema in humans.
Cohen JA; Fisher RS; Brigell MG; Peyster RG; Sze G
Epilepsia; 2000 Feb; 41(2):148-57. PubMed ID: 10691111
[TBL] [Abstract][Full Text] [Related]
20. Vigabatrin retinal toxicity in children with infantile spasms: An observational cohort study.
Akula JD
Neurology; 2015 Aug; 85(7):655-6. PubMed ID: 26283761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
